Objective evaluation of clinical actionability for genes involved in myopathies: 63 genes with a medical value for patient care

HIGHLIGHTS

• who: Maude Vecten and collaborators from the Département de Génétique, Hôpital Bichat-Claude-Bernard, APHP, Paris, France have published the Article: Objective Evaluation of Clinical Actionability for Genes Involved in Myopathies: 63 Genes with a Medical Value for Patient Care, in the Journal: (JOURNAL) of 10/02/2020
• what: In the project the authors carried out an objective assessment of the clinical actionability of genes involved in myopathies for which only __NEWPAGE__Int.

SUMMARY

The authors used the semi-quantitative actionability metric established by ClinGen to score the . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.